课题基金 / 基金详情

COVID-19 Sample Collection and Vaccine Studies

COVID-19 Sample Collection and Vaccine Studies
COVID-19 样本采集和疫苗研究
批准号：
10275375
负责人：
Julie E. Ledgerwood
金额：
$59.28万
依托单位：
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/10275375
关键词：
2019-nCoVAdultBiologicalBiological AssayCOVID-19DevelopmentDoseEvaluationHumanImmune responseImmunityImmunologyIndividualInfectionInvestigationMeasuresMessenger RNAMissionPhasePreventiveProtocols documentationResearchResearch SupportSafetySamplingSeverity of illnessTherapeuticVaccinesimmune functionimmunogenicityopen labelresearch studysafety studysample collectionvaccine candidatevaccine trial

项目摘要

项目成果

Julie E. Ledgerwood的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The evaluation of a vaccine candidate targeting COVID-19 and collection of samples to support translational immunology research support the broader VRC mission. For this project, sample collection was conducted under the VRC 200 protocol while the evaluation of an investigational vaccine candidate was conducted under the DMID 20-003 protocol. VRC 200: A Multicenter Specimen Collection Protocol to Obtain Human Biological Samples for Research Studies DMID 20-0003: Phase I, Open-Label, Dose-Ranging Study of the Safety and Immunogenicity of 2019-nCoV Vaccine (mRNA-1273) in Healthy Adults
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biodefense and Emerging Infectious Disease Vaccine Studies
Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies
Sample Collection and General Screening Protocols
Sample Collection and General Screening Protocols
海外基金